ID

16563

Description

Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00098566

Link

https://clinicaltrials.gov/show/NCT00098566

Keywords

Versions (1)
  1. 7/24/16 7/24/16 -
Uploaded on

July 24, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma NCT00098566

English

Eligibility Lymphoma NCT00098566

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00098566
Criteria
Description

Criteria

diagnosis of b-cell non-hodgkin's lymphoma
Description

b-cell non-hodgkins lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0024305
relapsed or refractory disease
Description

relapsed or refractory disease

Data type

boolean

Alias
UMLS CUI [1]
C0277556
previously treated with myeloablative doses of iodine i^131 tositumomab and autologous bone marrow or stem cell transplantation on 1 of the following phase i or ii protocols:
Description

previous therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0768182
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C1504389
fhcrc-296
Description

fhcrc-296

Data type

boolean

fhcrc-521
Description

fhcrc-521

Data type

boolean

fhcrc-792
Description

fhcrc-792

Data type

boolean

fhcrc-915
Description

fhcrc-915

Data type

boolean

patient characteristics:
Description

ID.8

Data type

boolean

18 and over
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
performance status
Description

performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
not specified
Description

ID.11

Data type

boolean

life expectancy
Description

life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
not specified
Description

ID.13

Data type

boolean

hematopoietic
Description

hematopoietic

Data type

boolean

Alias
UMLS CUI [1]
C0229601
not specified
Description

ID.15

Data type

boolean

hepatic
Description

hepatic

Data type

boolean

Alias
UMLS CUI [1]
C0205054
not specified
Description

ID.17

Data type

boolean

renal
Description

renal

Data type

boolean

Alias
UMLS CUI [1]
C0022646
not specified
Description

ID.19

Data type

boolean

prior concurrent therapy:
Description

prior concurrent therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0009429
biologic therapy
Description

biologic therapy

Data type

boolean

Alias
UMLS CUI [1]
C0005527
see disease characteristics
Description

ID.22

Data type

boolean

chemotherapy
Description

chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
not specified
Description

ID.24

Data type

boolean

endocrine therapy
Description

endocrine therapy

Data type

boolean

Alias
UMLS CUI [1]
C0279025
not specified
Description

ID.26

Data type

boolean

radiotherapy
Description

radiotherapy

Data type

boolean

Alias
UMLS CUI [1]
C1522449
see disease characteristics
Description

ID.28

Data type

boolean

surgery
Description

surgery

Data type

boolean

Alias
UMLS CUI [1]
C0543467
not specified
Description

ID.30

Data type

boolean

Back to the top of the page

Similar models

Eligibility Lymphoma NCT00098566

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00098566
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
b-cell non-hodgkins lymphoma
Item
diagnosis of b-cell non-hodgkin's lymphoma
boolean
C0024305 (UMLS CUI [1])
relapsed or refractory disease
Item
relapsed or refractory disease
boolean
C0277556 (UMLS CUI [1])
previous therapy
Item
previously treated with myeloablative doses of iodine i^131 tositumomab and autologous bone marrow or stem cell transplantation on 1 of the following phase i or ii protocols:
boolean
C1514463 (UMLS CUI [1,1])
C0768182 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C1504389 (UMLS CUI [2,2])
fhcrc-296
Item
fhcrc-296
boolean
fhcrc-521
Item
fhcrc-521
boolean
fhcrc-792
Item
fhcrc-792
boolean
fhcrc-915
Item
fhcrc-915
boolean
ID.8
Item
patient characteristics:
boolean
age
Item
18 and over
boolean
C0001779 (UMLS CUI [1])
performance status
Item
performance status
boolean
C1520224 (UMLS CUI [1])
ID.11
Item
not specified
boolean
life expectancy
Item
life expectancy
boolean
C0023671 (UMLS CUI [1])
ID.13
Item
not specified
boolean
hematopoietic
Item
hematopoietic
boolean
C0229601 (UMLS CUI [1])
ID.15
Item
not specified
boolean
hepatic
Item
hepatic
boolean
C0205054 (UMLS CUI [1])
ID.17
Item
not specified
boolean
renal
Item
renal
boolean
C0022646 (UMLS CUI [1])
ID.19
Item
not specified
boolean
prior concurrent therapy
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1,1])
C0009429 (UMLS CUI [1,2])
biologic therapy
Item
biologic therapy
boolean
C0005527 (UMLS CUI [1])
ID.22
Item
see disease characteristics
boolean
chemotherapy
Item
chemotherapy
boolean
C0392920 (UMLS CUI [1])
ID.24
Item
not specified
boolean
endocrine therapy
Item
endocrine therapy
boolean
C0279025 (UMLS CUI [1])
ID.26
Item
not specified
boolean
radiotherapy
Item
radiotherapy
boolean
C1522449 (UMLS CUI [1])
ID.28
Item
see disease characteristics
boolean
surgery
Item
surgery
boolean
C0543467 (UMLS CUI [1])
ID.30
Item
not specified
boolean
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial